Avidity Biosciences Honors Rare Disease Day® [Yahoo! Finance]
Avidity Biosciences, Inc. (RNA)
Company Research
Source: Yahoo! Finance
RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its support for Rare Disease Day ® , highlighting the importance of bringing awareness to the devastating impact rare diseases have on patients, families and caregivers worldwide. "Today, on Rare Disease Day, we are proud to join the global community in raising awareness for people living with rare diseases," said Sarah Boyce , president and chief executive officer at Avidity. "Recently, we had the privilege of hosting individuals affected by rare muscle diseases at Avidity. Their journeys, filled with challenges, determination, and unwavering hope, exemplify the urgency of our mission to profoundly improve people's lives by revolutionizing a new class of targeted RNA therapeutics. At Avidity, we are committed to listening, learning, and partnering with the patient and advocacy community and look forward to our continued collaboration as we advance our three rare muscle disease clinical programs for
Show less
Read more
Impact Snapshot
Event Time:
RNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RNA alerts
High impacting Avidity Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RNA
News
- Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
- Artisan International Small-Mid Fund Q1 2024 Earnings Preview [Seeking Alpha]Seeking Alpha
- Strategies for Global Clinical Trials: Clinical Research Without Borders, Upcoming Webinar Hosted by XtalksPR Web
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- FYBR, BCRX and SABR are among after hour movers [Seeking Alpha]Seeking Alpha
RNA
Earnings
- 2/28/24 - Miss
RNA
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- RNA's page on the SEC website